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Female genital schistosomiasisIn recent years, control of neglected tropical diseases has been increasingly gaining momentum and
interventions against schistosomiasis are being progressively scaled-up through expansion of donated
praziquantel and preventive chemotherapy campaigns. However, the public health importance of female
genital schistosomiasis is not fully recognised nor its control is adequately addressed. Taking a clinical
and anatomopathological perspective, we evaluated the available literature to highlight the importance
of female genital schistosomiasis and its connections with two sexually transmitted infections of global
importance, Human Immunodeficiency Virus (HIV) and Human Papilloma Virus. Outside the long list of
clinical descriptive reports beginning in 1899, there is presently a shocking gap in epidemiological assess-
ment and a significant underestimation of the burden of FGS remains. The scarcity of integrated
approaches to address female genital schistosomiasis calls for more concerted action in its detection,
treatment and prevention alongside other concomitant women’s health issues, otherwise female genital
schistosomiasis will remain a neglected gynaecological disease.
 2016 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Schistosomiasis is a water-borne parasitic disease caused by
infection with trematode worms of the genus Schistosoma. The dis-
ease was originally described in Egypt by Theodor Bilharz in 1851
and today can be found throughout Africa, South America and Asia
(Colley et al., 2014). Infection may affect humans of all ages and
genders, and globally it has the highest burden of disease among
the 17 recognised neglected tropical diseases (World Health
Organization (WHO), 2016b). Owing to a variety of factors
underlying an individual’s exposure and infection, there can be
substantial differences in prevalence and intensity of infection
across communities, as well as an associated spectrum in the
severity of disease. These manifestations are determined by a
number of causal factors such as the species of schistosome,
the duration of infection, host-specific factors that influence
immuno-pathological lesions to the worm eggs and access
to praziquantel treatment (Hirayama, 2006). Furthermore, asindividuals rarely harbour schistosomiasis alone, prior infection
with Schistosoma can increase the severity of other bacterial,
protozoal or helminth infections acquired later (Abruzzi and
Fried, 2011).
Schistosomiasis can be broadly classified as either acute or
chronic presentations (Colley et al., 2014). Upon initial percuta-
neous infection by cercariae, acute symptoms may include der-
matitis, then later non-specific symptoms of fever, headache and
cough. Acute symptoms normally resolve in a few weeks but in
exceptional cases, death by hyper-infection may occur. As adult
schistosomes mature within the body and commence egg deposi-
tion, chronic manifestations ensue, typically related to immuno-
pathological lesions and the formation of granulomata in various
organs around eggs (Colley et al., 2014). The involvement of the
intestinal tract with hepato-splenic disease and the urinary tract
with its associated organs is well-known (Centers for Disease Con-
trol and Prevention (CDC), 2012 http://www.cdc.gov/parasites/
schistosomiasis/disease.html; WHO, 2016, http://www.who.int/
mediacentre/factsheets/fs115/en/). Since eggs can be found
throughout the body in variable amounts, other clinical and patho-
logical diseases can be found in the heart, lungs, brain and spinal
cord as well as in the genital organs of both genders (Barsoum
et al., 2013).
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eggs in the genitalia of women have been defined as a particular
entity called female genital schistosomiasis (FGS). In 1997, the
Gender Task Force of the Tropical Disease Research Programme
(TDR) of the WHO included FGS in a list of scientific areas that
deserve higher research priority (Poggensee et al., 1999). Since
then, however, the extent of morbidity ascribed to FGS, which
can be found in both the lower and upper genital tract, has contin-
ued to be insufficiently addressed. Moreover, FGS has failed to be
reported at national levels which has hampered an international
appraisal. As an unfortunate outcome, prevention and control of
FGS is largely disconnected from global efforts to improve the
reproductive and sexual health of women. To address this, we
attempted to draw together the available literature to give a conti-
nental perspective and highlight how FGS should be integrated
into a broader vision of improving women’s health.
2. Methodology
PubMed was used as the search tool. The key words used to
gather information on FGS in general were ‘female’, ‘genital’ and ‘
schistosomiasis’. Only publications treating the clinical and anato-
mopathological aspects of FGS were selected and mapped or
displayed in the table. Articles published between 1899 and
September 2015 were included. Articles in English, French, German
and Spanish were considered. Articles in Portuguese, Japanese or
Chinese were included only as cited in Table 1 or Fig. 1. A specific
review was performed on FGS attributed to Schistosoma haemato-
bium and its association with HIV infection. The following
keywords were used: ‘HIV’ OR ‘acquired immunodeficiency
syndrome’ AND ‘schistosomiasis’ OR ‘bilharzia’ or ‘haematobium’.
Owing to their wider implications, publications that addressed
schistosomiasis during pregnancy and HPV/cervical cancer, when
encountered during the initial literature review, were also
inspected but the topic was formalised in the initial search
algorithm.Table 1
Forty-six publications out of the 193 reviewed papers are from Europe, USA and Ocean
schistosomiasis endemic countries. The table provides an overview of countries of diagno
spp.
Country of
diagnosis
Schistosomiasis infestation
origin
Age (years) Schistosomiasis-as
UK Malawi Lake, Zimbabwe (t),
Zambia, Nigeria, Zimbabwe
(m)
34, 43, 51, 26,
39, 37, 27, 31,
28, 29, 28, 29
Vulvar granuloma
carcinoma, ectopic
cervicitis, cervical
USA Senegal, East Africa, Liberia,
Guinea, South Africa (m)
27, 20, 28, 41,
22, 20, 63, 32,
37
Cervical dysplasia
HIV, sandy patches
infertility, perianal
France DRC (m), Mauritania (m),
Senegal (ms), Tunisia (m),
Mali (m), Mali (t), Senegal (m)
28, 34, 22, 29,
32, 35, 29, 21,
33, 27
Infertility, cervical
hydrosalpinx, adne
endometritis, ectop
Germany Angola, Sierra Leone, Togo (m) 24, 30, 21 Ectopic pregnancy,
Netherlands Malawi Lake, Mali (t) 37, 33 Leiomyoma, inferti
Spain Nigeria (m) Mali (t) 26 Infertility, vulvitis
Switzerland Egypt, Malawi Lake (t) 54, 26 Vulvar granuloma,
schistosomiasis, vu
Portugal Ovarian schistosom
Australia
Belgium Mali, Senegal (t) 20 Vulvar mass
Czech Rep. Brazil Hydrosalpynx, tuba
Israel Ethiopia (m) 19 Recto-vaginal fistu
Ireland Nigeria (m) 31 Ectopic pregnancy,
Italy South Tunisia (t) Vaginal mass
New
Zealand
Malawi Lake 30, 28 Adnexal mass, vulv
m, migrants; t, travellers; HPV, human papilloma virus; HIV, human immunodeficiency3. An overview of the FGS literature
A total of 193 publications featuring reports on the clinical and
pathological presentation of FGS were identified while preparing
this review. A considerable proportion describe African cases pub-
lished during the colonial era (Fig. 1). Some 44 publications were
from Europe, USA and Oceania, describing FGS in migrants or trav-
ellers coming from schistosomiasis-endemic countries (Table 1).
The large majority of the reviewed publications were case reports
or case series; the oldest published FGS case was reported in the
Lancet in 1899 (Madden, 1899). The analysis of case reports and
case series shows that every female genital organ (vulva, vagina,
uterine cervix, uterine body, Fallopian tubes and ovaries) can be
affected by schistosomiasis. We note that uterine body involve-
ment is greatly under-reported in such reports, being clearly
revealed upon comparison with findings from post-mortem stud-
ies. These latter studies demonstrate that the most frequently
affected gynaecological organs are the uterine cervix and the
uterine body, followed by the adnexa and the vulvo-vagina
(Charlewood et al., 1949; Gelfand and Ross, 1953; Youssef et al.,
1970; Gelfand et al., 1971; Edington et al., 1975). Of the three
schistosomes of most medical significance, the majority of FGS is
caused by S. haematobium but in Brazil, for example, FGS has been
shown to be caused by Schistosoma mansoni (Chaves and Palitot,
1964; Coelho et al., 1979; Poggensee et al., 2001; Downs et al.,
2011; Goncalves Amorim et al., 2014). In Asia, cases of FGS have
also been described as resultant from Schistosoma japonicum. Less
important schistosome species such as Schistosoma intercalatum
have also been shown to cause FGS (Koller, 1975; Berry, 1976;
Yang, 1984; Picaud et al., 1990; Qunhua et al., 2000; WHO, 2016,
http://www.who.int/schistosomiasis/genital_schistosomiasis/en/).
Most of the FGS cases reported before 1990 probably underrep-
resented the real burden of FGS for, in our opinion, they were based
on reports from African urban centres or in northern countries
where more advanced screening tools were available. Several
more recent studies attempted to address this systemic bias byia describing Female Genital Schistosomiasis in migrants or travellers coming from
sis, countries of infection, patient number and age, clinical condition and Schistosoma
sociated clinical condition Schistosoma spp. Publication
reference
number
(3 cases), adnexal mass, infertility, tubal
pregnancy, teratoma, HPV/HIV infection,
carcinoma in situ
S. haematobium 14, 17, 37,
107, 147, 148,
156, 168, 183
with HPV, cervical dysplasia with HPV/
, ectopic pregnancy, salpingitis,
fistula, cervical cancer without HPV
S. haematobium, S.
mansoni (1 case)
2, 13, 45, 54,
93, 131, 154
dysplasia, tubal obstruction,
xal mass, secondary amenorrhea,
ic pregnancy
S. haematobium, S.
mansoni (DRC, 1
case from Senegal)
51, 58, 60,
108, 123, 124,
165
leiomyoma, infertility, adnexal tumour S. haematobium 86, 118, 161
lity S. mansoni, S.
haematobium
29, 79
S. haematobium 15, 50
asymptomatic ovarian and tubal
lvar lesion and cervical lesions
S. haematobium 28, 76, 105
iasis, external genital mass 104, 179
91
S. haematobium 39
l schistosomiasis S. mansoni 136
la 102
tubal schistosomiasis 67
S. haematobium 23
ar lesion S. haematobium 52, 111
virus.
Fig. 1. Map indicating all publications reviewed with a considerable proportion of papers describing African cases published during the colonial era, followed by Brazil. Each
hexagon represents one publication with its respective reference number. The years of publication are classified into three groups of colour shades: light colours show
publications before 1986; medium colours show those between 1986 and 2000 and dark colours those from 2001 to 2015. In particular, the two last groups highlight a time
period before and after the World Health Assembly (WHA) resolution 54.19 in 2001, which promotes regular chemotherapy for school-age children and women to reduce
morbidity. Map modified from Gryseels et al. (2006).
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rural communities known to be endemic for schistosomiasis. These
studies assessed the cervical form of FGS (diagnosed by biopsy
except in the Talaat study (Talaat et al., 2004) in the frame of schis-
tosomiasis screening studies targeting the general population in
regions known to be endemic for schistosomiasis in Madagascar,
Tanzania, Malawi, Niger and Egypt. In these studies, cervicovaginal
schistosomiasis prevalence ranged from 33% (95% confidence
interval (CI): 19–51) in Madagascar to 75% (95% CI 65–87) in Niger,
with Tanzania and Egypt in between (Renaud et al., 1989;
Leutscher et al., 1998; Poggensee et al., 2000; Talaat et al., 2004;
Kjetland et al., 2005).
Another systematic bias apparent in the literature is that most
FGS cases were reported in women less than 30 years of age, how-
ever, this probably reflects the age of the studied population and
not the true age distribution of FGS. Symptoms attributable to
FGS have been reported in young children (Hegertun et al., 2013)
particularly the vulvo-vaginal forms (Berry, 1966; Al-Adnani and
Saleh, 1982; Gouzouv et al., 1984), as well as in post-menopausal
women (Berry, 1966; McKee et al., 1983; Arora et al., 1986;
Billy-Brissac et al., 1994; Nouhou et al., 1998; North et al., 2003).
With the above considerations, the examined literature report-
ing FGS cases from Africa and Brazil were mapped to show their
geographical distribution with the underlying prevalence of
S. haematobium and S. mansoni (Fig. 1). The years of publication
are classified into three groups: before 1986; between 1986 and
2000 and from 2001 to 2015. In particular, the two last groups
highlight a similar time period (15 years) before and after the
WHO World Health Assembly (WHA) resolution number 54.19
endorsed in 2001 which promotes regular chemotherapy for
school-age children and women to reduce morbidity due to schis-
tosomiasis and soil transmitted helminths (STH). Publications
reporting FGS cases in other parts of the world are also listed
(Fig. 1). It should also be noted that FGS can be associated with
active egg-patent excretion but can also be present without eggs
detected in urine or stools. For example, several studies showed
a prevalence of cervico-vaginal schistosomiasis of 55–75% in
women with S. haematobium eggs detected in urine (Kjetlandet al., 1996; Leutscher et al., 1997; Poggensee et al., 1998), whereas
in other studies, up to one-fourth of cervical lesions were present
without eggs being detected in urine (Nouhou et al., 1998;
Poggensee et al., 1998; Kjetland et al., 2005, 2008; Shennan and
Gelfand, 1971). The imprecise relationship between FGS and egg-
patent urogenital schistosomiasis confounds attempts to estimate
the number of women with, or at risk of FGS with current esti-
mates for those with urogenital schistosomiasis. By examining
the literature relative to the clinical presentation and the reported
consequences of FGS, as well as the potential relationship
with other sexually transmitted diseases, we seek to reposition
schistosomiasis in the broader context of gynaecological diseases.4. Schistosomiasis and female genital pathologies
The clinical symptoms of FGS are in general non-specific and
can be similar to those resulting from other causes. Clinical diagno-
sis requires trained health care professionals and/or histopatholog-
ical visualisation of the eggs in the lesions. FGS cases have been
reported in African women, African migrants or European or
American travellers, and in some instances they had a similar
clinical presentation. In the following section we highlight the
pathological conditions affecting the female genital tract, however
the recurrent challenge is to assess whether schistosomiasis is
directly implicated in the pathological process or if it is just an
incidental finding in the biopsies or in the anatomopathological
tissue samples. In most of the case reports the causal relationship
is well based, however in some of the cases reported in anato-
mopathological series the causal relationship is sometimes less
obvious and the conclusions cannot be clearly supported.4.1. Schistosomiasis and ectopic pregnancy (EP)
Ectopic pregnancy (EP) is a pregnancy that occurs outside the
uterine cavity. Tubal pregnancy is the implantation of the embryo
in the Fallopian tube and is the most frequent type of EP.
It is potentially a deadly condition as it can occasion severe
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gency surgical intervention (Bugalho et al., 1991b). EPs attributed
to schistosomiasis have been repeatedly reported in many geo-
graphical areas between 1943 and 2013 and by several authors,
i.e.: in Mozambique in a series of 103 cases of EPs, 4 out of 103
were attributed to a genital foci of schistosomiasis (Bugalho
et al., 1991a,b). In Ivory Coast 12 out of 331 cases of EPs were asso-
ciated with tubal schistosomiasis. In Loubière’s anatomopatholog-
ical series (Loubière et al., 1977), 15 Fallopian tubes out of 32 cases
of tubal schistosomiasis were removed due to tubal pregnancy.
Schistosoma granuloma was always present but sometimes not
prominent enough to be considered as the causal factor except in
one case of a bilateral tubal schistosomiasis due to S. mansoni
which was responsible for bilateral EPs (Loubière et al., 1977).
Two cases of tubal pregnancies in a series of 17 utero-adnexal
schistosomiasis cases were described by Diouf et al. (1973).
Although two studies from the 1970s comparing cases and con-
trols failed to demonstrate any association between schistosomia-
sis and EPs (Bland and Gelfand, 1970a; Frost, 1975), tubal
pregnancy was considered as the consequence of tubal alteration
due to schistosomiasis granulomata and/or salpingitis in the anato-
mopathological analysis of a salpingectomy specimen in the
following cases: Gilbert (1943), El-Bedri, (1958), Hassim, (1966),
Rosen and Kim, (1974), Vass and Lucey, (1982), Yang, (1984),
Okonofua et al. (1990), Ekoukou et al. (1995), Nouhou et al.
(1998), Schneider and Steyn (2000), Woto-Gaye et al. (2000),
Eogan et al. (2002), Hoffmann and Bauerfeind (2003), Garba et al.
(2004), Mohammed et al. (2004), Bahrami et al. (2006), Laxman
et al. (2008), Owusu-Bempah et al. (2013), Sahu et al. (2013),
Aminu et al. (2014). Most of the previous cases were reported in
African residents or migrants, one in a traveller, one in a Chinese
resident, one in an Indian and one in an Iraqui woman. Two cases
were attributed to S. mansoni and one to S. japonicum. The possible
physiopathological mechanism as to how schistosomiasis can
increase the risk of EP could be due to tubal submucosa alteration.
Mucosal alteration have also been described (Mohammed et al.,
2004), which rarely results in an obstruction but could induce a
loss of tubal elasticity. This would affect the peristalsis of the tube
and the ovum carriage. Fertilisation may occur and the conceptus
implants in the tubal mucosa instead of uterine cavity (Bland
and Gelfand, 1970a; Ville et al., 1991; Hoffmann and Bauerfeind,
2003). Several descriptions of surgical procedures report peri-
toneal, peri-ovarian and/or peri-tubal adherences, reflecting a
chronic inflammatory process associated with chronic schistoso-
miasis infection (Mensah et al., 1972; Schneider and Steyn, 2000;
Bahrami et al., 2006).
4.2. Schistosomiasis and sub-fertility and infertility
It is estimated that female causes of infertility account for
between 25% and 37% of infertility worldwide, with the largest
proportions in sub-Saharan Africa and south-eastern Asia, which
are the regions with the highest worldwide prevalence of schisto-
somiasis and FGS (Nguyen and Kols, 1997). Two case-control stud-
ies have shown a significant association between S. haematobium
and infertility. One study was conducted in 483 Zimbabwean
women whose husbands’ infertility had been excluded. The pres-
ence of Schistosoma eggs in the cervical smear was significantly
associated with infertility (Odd ratio (OR): 3.6 (95%CI: 1.05–12;
P = 0.041) (Kjetland et al., 2010a,b). The second study which was
done in Malawi showed a significantly higher proportion of infec-
tion with S. haematobium in a group of primary and secondary
infertile women than in fertile controls (41.3% versus 21.4%;
P < 0.02) (Bullough, 1976).
In a study in Pemba Island, Zanibar, tubal schistosomiasis was
found in 40% of the cases of primary or secondary infertility(Scheller, 1971). In Niger a prevalence of 38.5% of urinary schisto-
somiasis was found in 109 women with infertility. Women with
schistosomiasis presented more lesions of the female genital tract
(cervicitis, adnexal mass) than those who were not infected
(Nayama et al., 2007). In the analysis of 111 patients with female
genital schistosomiasis in Tanzania, Swai et al. (2006) reported
7% infertility.
Infertility was often the only reason leading to the histopatholog-
ical diagnosis of schistosomiasis involvement of the upper genital
tract. In many cases there were no other symptoms (Adeniji, 2001).
Occasionally the schistosomiasis finding was reported as incidental
(DeMille et al., 1995; Goverde et al., 1996), however, in most cases
infertility was attributed to Schistosoma lesions found in the Fallop-
ian tubes. As for EPs attributed to schistosomiasis, the surgical
procedures often described important peritoneal, peri-ovarian and
peri-tubal adherences (Gilbert, 1943; Seneze et al., 1963; Mouktar,
1966; Diouf et al., 1973; Bailey et al., 2011; Cornier et al., 1981;
El-Mahgoub, 1982; El-maraghy et al., 1982; Harouny and Pedersen,
1988; Letterie and Sakas, 1991; Morice et al., 1993, 1996; Ogunniyi
et al., 1994; Balasch et al., 1995; Schroers et al., 1995; Nouhou
et al., 1998; Swai et al., 2006; Schanz et al., 2010). Two cases of infer-
tility associated with endometrium pathology have been reported
(Le Guyader et al., 1965; Krolikowski et al., 1995). Tuberculosis has
been reported concomitantly to peritoneo-tubal schistosomiasis in
an infertile woman (Ekoukou et al., 1995). Tuberculosis granuloma
in the genitals is the main differential diagnosis of schistosoma
granuloma in the genital tract.
In two studies of female infertility where male causes were
excluded, El-Mahgoub (1972) evoked severalmechanisms of female
infertility induced by schistosomiasis: tubal obstruction, defective
luteal phase, anovulation or antispermatozoal antibodies. He also
reported the presence of antispermatozoal antibodies in 63% of
the 41 women with cervicovaginal schistosomiasis compared with
10% in a control group of women with urinary or gastrointestinal
schistosomiasis without FGS. (El-Mahgoub, 1972, 1982).
4.3. Schistosomiasis and adnexal mass
Ovarian or tubal adnexal masses associated with S. haemato-
bium, S. mansoni or S. japonicum infections have been reported
independently from infertility or EP cases. Lower abdominal pain
was sometimes the only clinical symptom (Gilbert, 1943; Ali
et al., 1956; Seif-Eldin, 1958; Carpenter et al., 1964; Diouf et al.,
1973; Gloor et al., 1979; Bac et al., 1987; Crump et al., 2000; Lee
et al., 2000; Shekhar et al., 2000; Lambertucci et al., 2009; Batista
et al., 2010; Bailey et al., 2011; Sedlis, 1961). Schistosomiasis
fibrous tumours involving the adnexa has been described in very
young girls (Symmers, cited in Camain et al. (1951)). Various types
of adnexal tumours associated with schistosomiasis have been
described such as arrhenoblastoma (Lemos et al., 1960; Foda
et al., 1961), cystadenoma (El-Maraghy et al., 1982), teratoma
(Paradinas, 1972; Sunder-Raj, 1976; Gigase and Vanderputte,
1980; Kahn et al., 1978), ovarian carcinoma (Goncalves Amorim
et al., 2014) ovarian Brenner cell tumour (Iskander and Kamel,
1968), ovarian thecoma (Onuigbo and Twomey, 1978) and one
carcinoma of the Fallopian tube (Beadles et al., 2007). An important
proportion of schistosomiasis adnexal involvement due to
S. haematobium or S. mansoni has been demonstrated in several
histopathological series (Arean, 1956; Badawy, 1962; Ricosse
et al., 1980; Al-Adnani and Saleh, 1982; Gouzouv et al., 1984;
Gwavava et al., 1984; Mohammed et al., 2007).
4.4. Schistosomiasis and vulvo-vaginal pathology
The first FGS report was published in 1899. It was a case of a
warty prominent mass in the vagina of an Egyptian woman
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associated with schistosomiasis have been described since then.
Schistosomiasis on the vulva or in the vagina, histopathologically
typically consists of a granuloma or a polypous/papillomatous
tumour (Scheller, 1971; Al-Adnani and Saleh, 1982; Helling-Giese
et al., 1996; Mohammed et al., 2007). Clinically it appears as a
swelling, wart, sore, plaque, bleeding pseudotumoural mass
(Ricosse et al., 1980; Wright et al., 1982). Vulvar schistosomiasis
lesions can be easily confounded with condyloma acuminata
(genital warts due to Human Papilloma Virus (HPV)) (Boulle and
Noreloviu, 1964; McKee et al., 1983; Samuel and Taylor, 2015) or
syphilis. Helling-Giese and colleagues have demonstrated that
polypoid/papillomatous tumours, in the vagina and vulva, can be
considered to be pathognomonic for FGS only in the absence of
HPV infection or syphilis (Helling-Giese et al., 1996). Prominent
lesions of the vulva were described in a series in Zambia in which
the mean age was 18 years (S.D. = 5) (Attili et al., 1983). Descrip-
tions of similar prominent lesions can also be found in earlier
publications (Kingsley, 1969; Gras et al., 1980). In post-mortem
studies (Gelfand et al., 1971; Edington et al., 1975), as in
histopathological series (van Raalte et al., 1981; Al-Adnani and
Saleh, 1982; Swai et al., 2006) vulvo-vaginal schistosomiasis
infections are predominantly found in young girls or teenagers.
Cases of vulvo-vaginal schistosomiasis have been also associated
with S. mansoni (Arean, 1956). Several cases of schistosomiasis
lesions of the vulva have been described in Europe and the USA
in migrants (Mawad et al., 1992) or travellers (Bianchi and De
Carneri, 1970; Leslie et al., 1993; Corachan et al., 1997; Blum
et al., 1998; Laven et al., 1998; Carey et al., 2001; Catteau et al.,
2011; Samuel and Taylor, 2015). Landry et al. (1996) described in
a female traveller a case of a vulvar schistosomiasis lesion 1 year
after a retrospective diagnosis of Katayama syndrome (fever due
to primary schistosomiasis infection in non-immune persons).
Vesico-vaginal fistulas (Servais, 1965; Ricosse et al., 1980; Kunin
et al., 1996) and perianal fistulas (DeMille et al., 1995), associated
with schistosomiasis, have been reported. In contrast, Bland did
not find any association between schistosomiasis and vesico-
vaginal fistula but patients with vesico-vaginal fistulas and
schistosomiasis were less likely to heal after surgical procedures
than those who did not have schistosomiasis (Bland and Gelfand,
1970b).
4.5. Schistosomiasis and uterine body-associated pathology
As previously noted clinical cases of schistosomiasis with
uterine body involvement are underreported compared with the
frequently described uterine body involvement in post-mortem
studies. This contradiction was already noted by Attia in his
review (Attia, 1962). In some recent publications, S. mansoni and
S. haematobium infections have been associated with leiomyoma
of the uterus, a pathology which is known to frequently affect
sub-Saharan African women (Boers et al., 2003; Mayr et al.,
2005; Cavalcanti et al., 2011; Hillers and Wiersema, 1961). A case
of endometritis due to the presence of the parasite in the intramu-
ral uterine vein in a 42 year old Chinese woman (Ching-ch’ien,
1951) and a Japanese case with endometrial schistosomiasis were
reported (Sugiyama et al., 1963). Cases of schistosomiasis
associated with pregnancy have been associated with stillbirths
(Narabayashi, 1914 cited in Carpenter et al., 1964; Youssef
and Abdine, 1958; Sutherland et al., 1965; Berry, 1966;
Bittencourt et al., 1980). One case control study examined the
impact of schistosomiasis on birth weight. While not showing
any differences in the delivery term, it did show that schistosomi-
asis in pregnant women was significantly associated with low
birth weight in preterm deliveries (Siegrist and Siegrist-Obimpeh,
1992).4.6. Schistosomiasis and cervical alterations
In anatomopathological case series and post-mortem studies,
the uterine cervix is the female genital organ most frequently
affected by schistosomiasis. Cervical schistosomiasis has been the
most studied aspect of FGS with many studies conducted during
the last 20 years by Feldmeier, Kjetland and associates. FGS clinical
presentation can be similar to other gynaecological pathologies
(sexually transmitted infection, endometriosis, etc). Several clinical
signs and symptoms have been significantly associated with
cervical schistosomiasis such as low abdominal pain, irregular
menstruation, cervical contact bleeding, abnormal vaginal dis-
charge, dysparunia, vaginal or cervical polyps, contact bleeding,
vulval itching and chronic cervicitis (Leutscher et al., 1998;
Anosike et al., 2003; Talaat et al., 2004; Swai et al., 2006). Rubbery
papules, sandy patches and neovascularization are cervical lesions
that have been statistically strongly associated with S. haemato-
bium, (Kjetland et al., 2005; Randrianasolo et al., 2015) and with
S. mansoni (Poggensee et al., 2001); grainy and yellow sandy
patches and rubbery papules being considered pathognomonic of
cervical schistosomiasis (Kjetland et al., 2012, 2014; Norseth
et al., 2014). In Europe and in the USA several cases of schistosomi-
asis have been diagnosed through cervical smears of women with
dysplasia (Adeniran et al., 2003; Chenault and Hoang, 2006;
Dzeing-Ella et al., 2009; Chen et al., 2012). Endocervical forms of
schistosomiasis such as polyps have been described as well (Eladl
et al., 2012; Delmondes et al., 2014). Three cases of schistostomia-
sis have been reported in HIV patients with cervical dysplasia or
carcinoma with HPV (Chenault and Hoang, 2006; Rachaneni
et al., 2007; Toller et al., 2015). In an observational study con-
ducted in the Limpopo province in South Africa, van Bogaert
(2011) found an HIV prevalence of 14% in 234 women with
biopsy-confirmed FGS, which is the expected HIV prevalence in
this region; schistosomiasis cervical involvement was observed in
the large majority of HIV-positive women and more frequently
than in the whole study group of (HIV+ and HIV) women with
FGS (94% versus 54%). Intraepithelial neoplasia was observed more
frequently in HIV-positive women than in the whole studied group
(50% versus 17.5%). HIV-infected women were significantly older
than women with FGS who were not infected with HIV (42 versus
35 years; P = 0.003) (van Bogaert, 2011).5. Schistosoma haematobium and HIV
In 1995, the first article suggesting FGS as a risk factor for HIV
was published, establishing a plausibility and prevalence correla-
tion between HIV and urinary schistosomiasis (Feldmeier et al.,
1995a,b). Since then, several studies documented that schistosomi-
asis of the uterine cervix is associated with disrupted epithelia,
neovascularisation, contact bleeding or spontaneous bleeding
(Wright et al., 1982; Poggensee et al., 2000; Kjetland et al., 2005,
2006a,b, 2009; Swai et al., 2006; Jourdan et al., 2011b, 2013), and
a higher density of HIV target cells; factors that predispose to
HIV infection (Jourdan et al., 2011a; Kleppa et al., 2014). While
the association between S. haematobium and HIV has been
documented in several observational studies, the association
between S. mansoni and HIV is less clear. Two case control studies
performed in comparable groups and adjusted for the main con-
founding factors showed two- to four-fold increased odds of HIV
in women with FGS due to S. haematobium (Kjetland et al.,
2006b) or urogenital schistosomiasis (Downs et al., 2011). In an
ecological study including 43 sub-Saharan African countries
Ndeffo Mbah et al. (2013b) demonstrated that each infection with
S. haematobium per 100 individuals was associated with a 2.9%
relative increase in HIV infection (95% CI: 0.2–5.8%; P = 0.038).
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between HIV and schistosomiasis epidemics and an impact of
schistosomiasis treatment on the HIV epidemic (Gibson et al.,
2010; Mushayabasa and Bhunu, 2011; Ndeffo Mbah et al.,
2013a). Furthermore, one of these studies showed the cost
effectiveness of a schistosomiasis intervention on HIV infection
prevention (Ndeffo Mbah et al., 2014). The main limitation of
the above cited observational studies is that they cannot prove
causality and some relevant confounding factors may have been
missed.
The interpretation of the results could be wrong if HIV infection
would occur before FGS and if it would induce more severe FGS
lesions (as it is the case for cervical dysplasia). Schistosomiasis
age prevalence curves and its genital manifestation before the
onset of sexual activity tend to make more it probable that schis-
tosomiasis infection and its related genital lesions occur before
HIV infection (Poggensee et al., 2000; Kjetland et al., 2005;
Hegertun et al., 2013). Moreover FGS clinical presentation does
not differ in HIV-infected women versus HIV non-infected women
(Kleppa et al., 2015). Egg excretion in urine might be increased in
HIV-positive women which would overestimate the association
but several studies have shown that egg excretion tends to be sim-
ilar or even lower in HIV-infected individuals with urinary schisto-
somiasis (N’Zoukoudi-N’Doundou et al., 1995; Mwanakasale et al.,
2003; Kallestrup et al., 2005; Kleppa et al., 2015).
6. Cervical schistosomiasis, HPV and cervical carcinoma
It is well established that cervical carcinoma is mainly due to
HPV infection. While the association between schistosomiasis
and cervical carcinoma remains unclear, several cases of cervical
carcinoma associated with schistosomiasis have been reported
many years ago (Chaves, 1966; Pimentafilho, 1964). In two
histopathological series, cervical carcinoma was found in 9–10%
of the studied cervical schistosomiasis cases (Badawy, 1962;
Gwavava et al., 1984). Payet and Camain (cited in Gwavava et al.
(1984)) found four cases of cervical cancer associated with schisto-
somiasis in a series of 38 cervical carcinoma cases. Youssef
reported 15 cases of invasive cervical carcinoma in which Schisto-
soma eggs were visualised microscopically out of 121 cases of
cervical schistosomiasis (Youssef et al., 1970). On the other hand,
other studies found no association between cervical carcinoma
and schistosomiasis (Williams, 1967; Coelho et al., 1979; Wright
et al., 1982; Szela et al., 1993). However, in one study when no
association between cervical cancer and cervical schistosomiasis
was found, it was observed that women affected with both schisto-
somiasis and cervical cancer were significantly younger than those
affected by cervical cancer only (Moubayed et al., 1994, 1995). This
could reflect the fact that young girls are more at risk of having FGS
but it could also be compatible with the hypothesis that schistoso-
miasis could increase the carcinogenic effect of HPV infection on
the uterine cervix by predisposing to HPV infection or favouring
its persistence as several authors have hypothesised. Indeed
Petry and colleagues (2003) found a higher proportion of high risk
HPV in the genitals of women from a schistosomiasis endemic area
compared with controls (Poggensee et al., 1999; Poggensee and
Feldmeier, 2001; Petry et al., 2003). More recently a longitudinal
study showed that the development of high-grade squamous
intraepithelial neoplasia was significantly associated with FGS of
a minimum of 5 years duration, while no association was found
between FGS and persistent high-risk HPV (Kjetland, 2010).
7. Discussion
The majority of the publications examined in this review were
case reports or case series. The few general population basedstudies were mostly performed in S. haematobium endemic
areas. Despite the relatively similar methodology, these studies
revealed significantly different results, which most likely
reflected the prevalence and intensity of schistosomiasis in the
studied areas. However, other reasons cannot be excluded and
deserve further research. Equally relevant is the lack of popula-
tion studies in areas endemic to S. mansoni (and eventually
S. japonicum), given the abundance of case reports of FGS associ-
ated with this species, particularly in Brazil (Fig. 1). Traditionally,
the interface between parasitology and gynaecology has been
weak and largely focused on diseases caused by protists e.g.
Trichomonas vaginalis. It has been only recently appreciated that
helminths, and particularly schistosomiasis, cause significant
damage to the female genitalia, as highlighted in a relevant
WHO document (WHO, 2016a).
Today, we appreciate many of the possible consequences of FGS
such as EP, infertility, spontaneous abortion, low premature infant
birth weight, possibly cervical cancers, cervical lesions and
especially its probable role in increasing susceptibility to other
infections such as HIV/AIDS, however we lack reliable up-to-date
epidemiological information on prevalence, incidence and geo-
graphical distribution of FGS. We can only make conservative
estimates of the overall prevalence of the disease and of the 250
million people infected with schistosomiasis, approximately two-
thirds of whom (ca. 170 million) are infected by the urogenital
form caused by S. haematobium (the form with the highest correla-
tion with cases of FGS). Among those 170 million, half of them are
women (ca. 85 million) and at least one-third of those women may
suffer from FGS. Of them, probably 20 million are girls or young
women, most of them lacking suitable medical attention (Hotez
and Whitham, 2014). We consider that this lack of validated
epidemiological information is the major impediment towards
bringing FGS to the forefront of strategic discussions not only in
the context of schistosomiasis disease control interventions, but
perhaps even more importantly, in the context of addressing
women’s health in the broadest sense including mental health,
sexually transmissible diseases, cancer and reproductive/maternal
health. This is especially important when considered in the context
of achieving the 2030 Sustainable Development Goals (SDGs) and
particularly SDG 3: ‘‘Ensure healthy lives and promote well-being
for all at all ages”. FGS falls within the targets set for SDG3 on at
least two accounts: ‘‘By 2030, ensure universal access to sexual
and reproductive health-care services, including for family
planning, information and education, and the integration of repro-
ductive health into national strategies and programmes” and ‘‘By
2030, end the epidemics of AIDS, tuberculosis, malaria and
neglected tropical diseases and combat hepatitis, water-borne
diseases and other communicable diseases”. (SDG 3 www.un.org/
sustainabledevelopment/sustainable-development-goals).
When examining the case reports, the vast majority of those
were in the context of medical care reports from women living in
schistosomiasis endemic countries or from individual cases of
tourists who acquired FGS in sub-Saharan countries and were
diagnosed in the well-equipped health care facilities of western
countries. In those reports it was often difficult to be affirmative
regarding the causal relationship between schistosomiasis and
the described pathology. The high number of FGS descriptions to
date has had little impact on performing large scale population
based studies to estimate more precisely the FGS burden and to
address its public health implications, particularly in relation to
gynaecological health or to highly prevalent infections such as
HIV or HPV. Therefore, well designed prospective studies address-
ing the full spectrum of potential target organs, particularly the
upper genital tract (Richter et al., 1995), should be conducted in
various schistosomiasis endemic areas (including S. mansoni and
S. japonicum).
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suggested studies resides in the difficulty associated with the diag-
nosis of FGS. While for FGS affecting the uterine cervix and vagina
the recently published WHO pocket atlas (http://pocketatlas.org)
and the supporting material sets clear criteria to identify the
lesions (Norseth et al., 2014), much work is needed to address
the diagnosis of lesions in other organs (Richter et al., 1995).
Furthermore, even with the available tools there is a great need
for trained personnel and appropriate equipment which are not
available in many endemic areas.
In terms of disease management, the current gold standard to
treat schistosomiasis is a single dose of 40 mg/kg of praziquantel
according to the WHO recommendation (WHO, 2016, http://
www.who.int/schistosomiasis/strategy/en/). Treatment with praz-
iquantel kills the adult worms and provides some regression of
inflammatory lesions. However, the recommended regimen is
probably not sufficient to prevent and eliminate the eggs associ-
ated with FGS (Richter et al., 1996; Poggensee and Feldmeier,
2001; Kjetland et al., 2006a, 2008; Downs et al., 2013). As a preven-
tive measure, regular praziquantel treatment starting in early
childhood (including pre-school age children) could be the most
effective intervention to prevent the occurrence and development
of future complications associated with genital schistosomiasis.
However, for a patient who presents herself with severe symptoms
of FGS there are no validated therapeutic options. Therefore, there
is a great need to search for treatment alternatives, focussing on
reducing the pathological process induced by the Schistosoma eggs,
alternative praziquantel doses or regimens aiming to achieve total
elimination of adult worms and therefore interrupting egg produc-
tion that sustains the pathology.
8. Conclusion
The clinical manifestations of FGS, since first reported in the
Lancet in 1899 (Madden, 1899), have been continuously described
through time in most schistosomiasis endemic areas affected by
different Schistosoma spp. While the original descriptions mostly
highlighted the macroscopic external lesions of the female genital
tract, today we know that it can affect all of the genital tract with
serious health implications. On the other hand, given the nature of
the reports, it is difficult to establish how large or extensive the
current burden of disease is; thus only crude extrapolations are
possible. FGS appears to be a prevailing condition even with the
progress achieved in the implementation of schistosomiasis
control strategies. Strategies fundamentally focus on (morbidity)
prevention while proper clinical and laboratory diagnosis of FGS
remains a significant issue and bottleneck. Women suffering from
FGS approach health care providers with complaints about
bleeding, infertility or suspicion of having sexually transmitted
infections, however little attention is provided because the
recognition and treatment of schistosomiasis genital tract lesions
requires well trained physicians and specialised infrastructure
which are not readily available in most schistosomiasis endemic
settings. The scarcity of integrated approaches to address FGS
calls for more concerted action in its detection, treatment and
prevention, otherwise it will remain a neglected gynaecological
disease.
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